Peter Attia· MD
the way to approach this problem would actually be finding surrogate biomarkers that you believe and trust that will hold long and behold for example we now maybe in the last five years have finally agreed that ldl cholesterol is a good target to lower for cardiovascular disease prevention although every now and then you'd get somebody who shows you lower ldl cholesterol may not translate into cardiovascular events but for the most of people in the field agree that lowering an ldl cholesterol by a statin or by azitomi or by any other measurement can associate with less atherosclerosis can we find a biomarker in 35 45 year old individuals a brain biomarker where if you change it you would convince most people that this may protect you against dementia or cognitive decline a couple of decades that's a fundamentally important question that needs to be tackled